|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$186,589,533 |
|
|
Indirect Value
|
$47,040,306 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$233,629,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-08-01 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-09-02 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-09-02 |
4 |
AS |
$108.30 |
$15,277,914 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-10-01 |
4 |
AS |
$105.70 |
$14,893,845 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-10-01 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-11-03 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-11-03 |
4 |
AS |
$109.78 |
$15,525,102 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-12-01 |
4 |
AS |
$100.48 |
$14,164,829 |
D/D |
(140,633) |
4,122,987 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-12-01 |
4 |
OE |
$8.01 |
$1,125,767 |
D/D |
140,633 |
4,263,620 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-10-22 |
4 |
OE |
$3.70 |
$521,542 |
D/D |
140,984 |
1,912,763 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-01-02 |
4 |
OE |
$15.27 |
$2,154,212 |
D/D |
141,121 |
2,143,853 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-01-02 |
4 |
AS |
$74.34 |
$10,508,472 |
D/D |
(141,121) |
2,002,732 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-02-07 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,094,665 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-02-07 |
4 |
AS |
$54.92 |
$8,013,529 |
D/D |
(145,450) |
1,949,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-03-01 |
4 |
AS |
$46.23 |
$6,723,804 |
D/D |
(145,450) |
1,949,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-03-01 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,094,665 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-04-02 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,134,655 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-04-02 |
4 |
AS |
$48.38 |
$7,036,842 |
D/D |
(145,450) |
1,989,205 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-05-01 |
4 |
AS |
$51.71 |
$7,521,496 |
D/D |
(145,450) |
1,989,205 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-05-01 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,134,655 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-06-01 |
4 |
AS |
$48.65 |
$7,091,410 |
D/D |
(145,450) |
1,989,205 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-06-01 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,134,655 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-07-02 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,135,388 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-07-02 |
4 |
AS |
$51.32 |
$7,464,683 |
D/D |
(145,450) |
1,989,938 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-08-01 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,135,388 |
0 |
- |
|
367 Records found
|
|
Page 12 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|